Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cowpox
Research findings from R.M. Vorou et al update understanding of cowpox
May 7th, 2008
Data detailed in 'Cowpox virus infection: an emerging health threat' have been presented. According to recent research from Athens, Greece, "Human cowpox, a rare zoonotic infection, evokes a self-limited disease, except for immunocompromised and eczematous patients, particularly children, where it can become severe. The causative agent, cowpox virus, is distributed in Europe, west former USSR, and adjacent areas of Northern and Central Asia, with an increasing number of reports in Europe." "The purpose of this paper is to review cowpox with an emphasis on its epidemiology and management. Numerous reports of human cowpox affecting young people in Europe indicate that...
Source: Vaccine Weekly (2008-05-07)
|
